Cookie Policy

Information about our use of cookies

This website is operated by Shield Therapeutics plc (“we” “our” “us”).

Our site uses cookies to distinguish you from other users of our site. This helps us to provide you with an enjoyable experience when you browse our site and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies. If you don’t want to receive cookies while browsing our site, you can modify your browser and/or mobile device settings so that it notifies you when receiving cookies or you can choose to restrict or block cookies.

What is a cookie

A cookie is a small file of letters and numbers that we store on your browser when you visit our site. Cookies are then sent back to the originating site on each subsequent visit, or to another website that recognizes that cookie.

Cookies we use

We use Google Analytics and its associated cookies to track and report traffic to our site and monitor user interaction. Amongst other things, it allows us to count the number of visitors to our site and to see how they move around the site. This helps us to improve the way our site works, for example, by ensuring that you find what you are looking for easily. Google Analytics and its cookies does not store personally identifiable data and its security and privacy principles can be found using the following link https://support.google.com/analytics/topic/2919631?hl=en&ref_topic=1008008.

We also use advertising cookies. These cookies are used by advertising companies to collect information about how you use our services and other websites over time. These companies use this information to show you ads they believe will be more relevant to you and measure how the ads perform.

How to control and delete cookies

The majority of web browsers accept cookies, but you can usually change the web browser’s settings to refuse new cookies, disable existing ones or simply let you know when new ones are sent to your device. In order to do this, follow the instructions provided by your browser. However, please be aware that, if you refuse or disable cookies, some of the website’s functionality may be lost. In addition, disabling a cookie or category of cookie does not delete the cookie from your browser, you will need to do this yourself from within your browser.

Changes to our use of cookies

Any changes we make to our Cookie Policy in the future will be posted on this page on our site. Please check back frequently to see any updates or changes to our Cookie Policy.

Contact Information

If you have any queries in relation to this notice, please contact us at privacy@shieldtx-us.com.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

ACCRUFeR is contraindicated in patients with a history of:

Hypersensitivity to ACCRUFeR or any of its inactive components

Hemochromatosis and other iron overload syndromes

Receiving repeated blood transfusions as this may result in iron overload

WARNINGS AND PRECAUTIONS

Increased Risk of Inflammatory Bowel Disease (IBD) Flares

Avoid use of ACCRUFeR in patients with an active IBD flare, as there is potential risk of increased inflammation in the gastrointestinal tract.

Iron Overload

Excessive therapy with iron products can lead to excess storage of iron with the possibility of iatrogenic hemosiderosis. Do not administer ACCRUFeR to patients with evidence of iron overload or patients receiving intravenous iron. Assess iron parameters prior to initiating ACCRUFeR and monitor iron parameters while on therapy.

Risk of Overdosage in Children Due to Accidental Ingestion

Accidental overdose of iron products is a leading cause of fatal poisoning in children under age 6. Keep out of reach of children.